Zealand reports royalty revenue for the third quarter of 2017
Nov 02, 2017 06:40 am UTC| Business
Company announcement - No. 49/2017 Zealand reports royalty revenue for the third quarter of 2017 Zealand reports royalty revenue of DKK 10.3 million/USD 1.6 million for Q3 2017 The revenue is based on total...
Galapagos moving forward in CF programs at NACFC 2017
Nov 02, 2017 06:32 am UTC| Business
Ten posters and four oral presentations reflect progress toward triple combination therapy Mechelen, Belgium; 2 November 2017; 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV...
Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
Nov 02, 2017 06:31 am UTC| Business
Paris, November 2, 2017 Q3 2017 Business EPS(1) up 1.1% at CER(2) FY 2017 Guidance Confirmed Q3 2017 Change Change at CER Change at CER/CS(3) 9M 2017 Change Change at CER Change at CER/CS(3) ...
Cleanroom Technology Market to Reach $5 Billion by 2023: P&S Market Research
Nov 02, 2017 06:30 am UTC| Business
NEW YORK, Nov. 02, 2017 -- The global cleanroom technology market is forecasted to attain $5.0 billion value by 2023, growing at a CAGR of 5.7% during 2017-2023. The growth in the market is likely to be led by increased...
Dutch Military Chooses Rainmaker Worldwide for Mission-Critical Military Base Water Supply
Nov 02, 2017 06:27 am UTC| Business
AMERSFOORT, The Netherlands, Nov. 02, 2017 -- The Dutch Ministry of Defense, has chosen Rainmaker Worldwide, working in collaboration with its partner, Bredenoord to provide water purification systems on military bases...
Basilea reports on commercial progress of antifungal Cresemba® in Europe
Nov 02, 2017 06:16 am UTC| Business
Cresemba launched by Pfizer in Spain and is now commercially available in all Top-5 EU marketsMarketing authorization received for Switzerland Basel, Switzerland, November 2, 2017 - Basilea Pharmaceutica Ltd....
Targovax ASA: Third quarter 2017 results
Nov 02, 2017 06:02 am UTC| Business
Oslo, Norway, 2 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its third quarter 2017 results. A meeting for...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma